The market has no idea of how well trials with the

New Post Public Reply Private Reply Replies (1) Message Board
GaryM Wocongming #10713
625
The market has no idea of how well trials with the sublingual tablet or psoriasis cream will go. Nor does the market have any idea how many countries or states will legalize cannabis over the next few years, or if the U.S. Govt. will reclassify it rather than fighting with the State's, and Congress over who can do what.

If you believe that because a stock is trending down it will do so forever because that's what the market is saying, how do you explain any company that's now trading at near it's 52 week highs, but which had 52 week lows that were dramatically below that high.

Last year I told people that IMGN, which hit lows not seen for roughly 10 years was a screaming buy at those lows. It's lowest was $1.51, I bought substantially more at $2 and $3. While it's 52 week high reached $8.84 and it's currently at $6.76, I still believe it will close the year well into double digits as year end conferences reveal more about its drugs in trials. By your logic, no one would have invested at the lows, and of course they'd not have tripled or better their money by now.

I certainly don't know how low OWCP may go, but it it's substantially lower than it is today, I'll probably average down again. In time trial news will be out, and in time product sales will begin. I don't believe that you can say that any of their products don't have blockbuster potential. Even if they partner and their royalty rates are just high single digits, they'll still be bringing in hundreds of millions annually. Of course if they wholly own one or more of their drugs they'll bring in a lot more, but naturally their up front cost will be far higher, it's not something they can do until at least a couple products are already in the marketplace with substantial sales.

For now, I await trial data for the psoriasis cream, which I believe will be positive and boost the stock price to $1 or more. After that I believe the next step will be additional partnerships for a variety of countries, and States, or a single one covering ROW.

Time will tell, by your theory it will just keep going down, because it's going down with no real news. By my theory their will be news, it will be good news, and the price in time will make new all time highs.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 5

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 6

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

TransUnion's Upcoming Investor Conferences and Opportunities

Updated Category News Views 170

TransUnion Set to Engage Investors at Major Conferences TransUnion (NYSE: TRU) has announced its participation in upcoming investor conferences that highlight the company's commitment to engaging its stakeholders. These events offer a platform for TransUnion's executives to showcase the company's strategies and insights into the market. Key Presentations Scheduled On a...

Continue Reading
BlackBerry and Microsoft Partner to Revolutionize Automotive Tech

Updated Category News Views 287

BlackBerry's Strategic Partnership with Microsoft Shares of BlackBerry Limited (NYSE: BB) surged by 9% after the announcement of an alliance between its QNX division and Microsoft. This collaboration is set to accelerate the development of Software-Defined Vehicles (SDVs), a groundbreaking area in automotive technology. Integrating Advanced Technologies The key aspect of...

Continue Reading
Explore the Compounding Power of Expedia Group Investment

Updated Category News Views 136

Understanding the Journey of Expedia Group Expedia Group (NASDAQ: EXPE) has showcased remarkable growth over the last two decades. If we look at its history, it becomes clear that investing in the right company can significantly impact wealth accumulation. With an average annual return of 12.29%, Expedia has outperformed the broader market by 3.62% on an annualized basis....

Continue Reading
Transforming Education: Empowering Teachers for Inclusion

Updated Category News Views 180

Empowering Educators for an Inclusive Future An initiative funded by Education Cannot Wait is transforming educational practices, training teachers in sign language and braille through a multi-year program in South Sudan. In a bright classroom setting, we find Beatrice, a 24-year-old aspiring educator. She confidently shares her experiences with fellow student teachers as...

Continue Reading
Anamana's Hit Show Ignites with Season 2 Return

Updated Category News Views 4

Lighting Up the Screen Again There's something special brewing over at Anamana. This August 15, the AI-native platform's breakout show, The Playboy Got Knocked Up, is back for a second season. You talk about a series that propelled itself into fame quicker than some IPOs I've seen! Started with a small budget of $4,000 for compute costs, this micro-serial isn't just a...

Continue Reading